|
GNTA
|
Genenta Science S.p.A.
|
US
|
NASDAQ
|
|
GRCL
|
Gracell Biotechnologies Inc.
|
US
|
NASDAQ
|
|
GRTS
|
Gritstone Oncology, Inc.
|
US
|
NASDAQ
|
|
HARP
|
Harpoon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HOWL
|
Werewolf Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IBRX
|
ImmunityBio, Inc.
|
US
|
NASDAQ
|
|
IMNM
|
Immunome, Inc.
|
US
|
NASDAQ
|
|
IMV
|
IMV Inc.
|
US
|
NASDAQ
|
|
INDP
|
Indaptus Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
MBIO
|
Mustang Bio, Inc.
|
US
|
NASDAQ
|
|
MDNA
|
Medicenna Therapeutics Corp.
|
US
|
NASDAQ
|
|
MRKR
|
Marker Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MRUS
|
Merus N.V.
|
US
|
NASDAQ
|
|
NBTX
|
Nanobiotix S.A.
|
US
|
NASDAQ
|
|
NLTX
|
Neoleukin Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ONCR
|
Oncorus, Inc.
|
US
|
NASDAQ
|
|
PDSB
|
PDS Biotechnology Corporation
|
US
|
NASDAQ
|
|
RCUS
|
Arcus Biosciences, Inc.
|
US
|
NYSE
|
|
SNSE
|
Sensei Biotherapeutics, Inc.
|
US
|
NASDAQ
|